Clinical Social Workers in Far Rockaway, NY Accepting Medicare
146 Clinical Social Workers found. Showing 141 - 146
 Mrs. Chedva Lax, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 156 Beach 9th St, Suite C, Far Rockaway, NY 11691 Phone: 347-695-9700 Fax: 347-695-9701 |
 Mr. Melech David Mann, MSW LISW EMDR Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1032 Bay 24th St, Far Rockaway, NY 11691 Phone: 929-278-0537 |
Golda Rockove, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 156 Beach 9th St, Far Rockaway, NY 11691 Phone: 718-686-3149 Fax: 718-686-4149 |
Mrs. Daniella Wieder, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 156 Beach 9th Street, Far Rockaway, NY 11691 Phone: 347-695-9700 Fax: 347-695-9701 |
Ms. Corinne R. Eisner, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 521 Beach 20th St, Far Rockaway, NY 11691 Phone: 718-869-8822 Fax: 718-869-8829 |
Joyce Rubin, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 156 Beach 9th St, Far Rockaway, NY 11691 Phone: 718-686-3149 Fax: 718-686-4149 |
News Archive
Connectivity, size of brain can predict degree of anxiety in young children
Prolonged stress and anxiety during childhood is a risk factor for developing anxiety disorders and depression later in life. Now, Stanford University School of Medicine researchers have shown that by measuring the size and connectivity of a part of the brain associated with processing emotion - the amygdala - they can predict the degree of anxiety a young child is experiencing in daily life.
"Check Yo Nutz" testicular cancer awareness campaign launched
Canisius College and Roswell Park Cancer Institute (RPCI) announce the launch of "Check Yo Nutz," the first comprehensive testicular cancer awareness campaign on a Western New York college campus. The campaign promotes testicular self-examination for men ages 15 - 40, through clear, informative, accurate, relatable and humorous messages.
Vanda second-quarter 2010 revenues decrease by $4.1M
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced financial and operational results for the second quarter and six months ended June 30, 2010.
FDA approves InSightec's ExAblate Neuro system clinical trial for tremor dominant Parkinson's Disease
InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration to begin a Phase I clinical trial evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor dominant Parkinson's Disease.
› Verified 1 days ago
Clinical Social Workers
Counselors
Occupational Therapists
Pharmacists
Psychologists
Dentists